Diagnostic pathways to cancer

  • A national survey in general practice in Denmark

Why is the survey important?

General practice plays a key role in the diagnosis of cancer, as most patients present the first symptoms of potential disease to their general practitioner (GP). Previous studies have described the pathways to cancer diagnosis in general practice. However, as the context has changed over the past decade due to developments in the healthcare system and in society, we need updated evidence to reflect current diagnostic pathways and inform future improvements in care.

This survey will provide new insights into the current diagnostic pathways in general practice. Such insight may help us optimise the existing pathways and support the diagnostic process in the future.


What does the survey contribute?

This survey on clinical pathways in general practice in the period leading up to a cancer diagnosis aims to provide nuanced insights into the current role of GPs within the wider healthcare system.

We aim to identify what the GP observes during the diagnostic pathway (and when), what raises the GP's suspicion of cancer, what diagnostic procedures are performed, and how the cancer type, presented symptoms, continuity and the patient's personal characteristics influence the diagnostic process.


Who can participate in the survey?

You may participate in the study if you are a GP working in Denmark and have received an invitation following a recent cancer diagnosis in one of your patients.


About CaP 2026

  • Cancer diagnostics in Practice (CaP) has previously been investigated in several cohorts.
  • Earlier studies have contributed new knowledge on the diagnosis and treatment of cancer.
  • This research has been instrumental in establishing cancer patient pathways in Denmark.
  • CaP26 focuses particularly on the routes to a cancer diagnosis in general practice.